T1	PROC 67 91	estudio de investigación
#1	AnnotatorNotes T1	C0681814; research study; Research Activity
T2	ANAT 831 841	autosomica
#2	AnnotatorNotes T2	C0596142; Autosome; Cell Component
T3	PROC 116 128	tratamientos
#3	AnnotatorNotes T3	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T4	DISO 149 159	enfermedad
#4	AnnotatorNotes T4	C0012634; Disease; Disease or Syndrome
T5	PROC 180 187	placebo
#5	AnnotatorNotes T5	C0032042; Placebos; Therapeutic or Preventive Procedure
T6	PROC 230 241	tratamiento
#6	AnnotatorNotes T6	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T7	DISO 248 292	enfermedad de Alzheimer autosómica dominante
T8	PROC 335 344	previenen
#7	AnnotatorNotes T8	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T9	Observation 370 393	alteraciones cerebrales
T10	DISO 430 455	síntomas de la enfermedad
#8	AnnotatorNotes T10	C0517730; Signs and symptoms of disease; Finding
T11	PROC 478 567	Estudio de fases II/III multicéntrico, aleatorizado, doble ciego y controlado con placebo
T12	PROC 576 584	terapias
#9	AnnotatorNotes T12	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T13	DISO 621 631	enfermedad
#10	AnnotatorNotes T13	C0012634; Disease; Disease or Syndrome
T14	DISO 688 733	enfermedad de Alzheimer hereditaria dominante
T15	DISO 757 780	Enfermedad de Alzheimer
#11	AnnotatorNotes T15	C0002395; Alzheimer's Disease; Disease or Syndrome
T16	DISO 807 851	Enfermedad de Alzheimer autosomica dominante
T17	ANAT 383 393	cerebrales
#12	AnnotatorNotes T17	C0242202; Cerebrum; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component | C1280654; Entire cerebrum; Body Part, Organ, or Organ Component
T18	Date 13 17	2013
T19	Spec_cue 107 115	posibles
T21	Spec_cue 320 322	si
T23	LIVB 635 645	individuos
#13	AnnotatorNotes T23	C0027361; Persons; Population Group
T24	Spec_cue 670 679	riesgo de
T20	PHYS 272 292	autosómica dominante
#14	AnnotatorNotes T20	C0443147; Autosomal dominant inheritance; Genetic Function
T25	PHYS 712 733	hereditaria dominante
#15	AnnotatorNotes T25	C0678942; dominant inheritance; Genetic Function
T22	PHYS 831 851	autosomica dominante
#16	AnnotatorNotes T22	C0443147; Autosomal dominant inheritance; Genetic Function
T26	ANAT 272 282	autosómica
#17	AnnotatorNotes T26	C0596142; Autosome; Cell Component
A1	Assertion T3 Speculated
A2	Assertion T8 Speculated
A3	Assertion T14 Speculated
#18	AnnotatorNotes T11	C1519042; Phase II/III Trial; Research Activity + C1096776; Multicenter Study; Research Activity + C0034656; Randomization; Research Activity + C0013072; Double-Blind Method; Research Activity + C2826345; Parallel Study; Research Activity 
T27	Neg_cue 189 191	no
T28	CHEM 201 220	componentes activos
#19	AnnotatorNotes T28	C1372955; Active ingredient; Chemical Viewed Functionally
A4	Assertion T28 Negated
T29	Spec_cue 589 598	potencial
T30	CONC 604 611	influir
A5	Assertion T30 Speculated
#20	AnnotatorNotes T30	C4054723; Influence; Conceptual Entity
T31	CONC 346 354	retrasan
A6	Assertion T31 Speculated
T32	CONC 357 365	corrigen
A7	Assertion T32 Speculated
#21	AnnotatorNotes T32	C2349182; Correct (qualifier); Qualitative Concept
R1	Speculation Arg1:T19 Arg2:T3	
T33	Quantifier_or_Qualifier 129 159	modificadores de la enfermedad
R2	Has_Quantifier_or_Qualifier Arg1:T3 Arg2:T33	
A8	Assertion T33 Speculated
R3	Speculation Arg1:T19 Arg2:T33	
R4	Negation Arg1:T27 Arg2:T28	
R5	Location_of Arg1:T26 Arg2:T20	
R6	Location_of Arg1:T17 Arg2:T9	
R7	Speculation Arg1:T21 Arg2:T8	
R8	Speculation Arg1:T21 Arg2:T31	
R9	Before Arg1:T3 Arg2:T8	
R10	Before Arg1:T5 Arg2:T8	
R15	Overlap Arg1:T9 Arg2:T10	
R16	Causes Arg1:T7 Arg2:T10	
R17	Overlap Arg1:T7 Arg2:T9	
#22	AnnotatorNotes T9	C0184524; Cerebral alteration; Finding
R18	Before Arg1:T8 Arg2:T9	
R19	Speculation Arg1:T29 Arg2:T30	
R21	Experiences Arg1:T23 Arg2:T12	
R22	Experiences Arg1:T23 Arg2:T13	
R23	Experiences Arg1:T23 Arg2:T14	
R24	Speculation Arg1:T24 Arg2:T14	
R25	Experiences Arg1:T23 Arg2:T25	
R26	Location_of Arg1:T2 Arg2:T22	
#23	AnnotatorNotes T31	C0205421; Deferred; Temporal Concept (?)
R11	Speculation Arg1:T21 Arg2:T32	
A9	Experiencer T23 Patient
